{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:29:23Z","timestamp":1790638163490,"version":"4.1.0"},"reference-count":228,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Astra Seneca"},{"name":"Avid Pharmaceuticals"},{"name":"Axovant"},{"DOI":"10.13039\/100004328","name":"Genentech Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lilly Pharmaceuticals"},{"DOI":"10.13039\/100004334","name":"Merck and Co.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Roche Diagnostics Corp."},{"name":"vTv Therapeutics and Piramal Imaging"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State of Arizona"},{"DOI":"10.13039\/100000049","name":"The National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG019795"],"award-info":[{"award-number":["R01 AG019795"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008225","name":"Midwestern University, Glendale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008225","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Life Extension Foundation, Inc"},{"name":"Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center"},{"name":"Arizona Alzheimer's Disease Consortium"},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-14-1-0467"],"award-info":[{"award-number":["W81XWH-14-1-0467"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U24 NS072026"],"award-info":[{"award-number":["U24 NS072026"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG19610"],"award-info":[{"award-number":["P30 AG19610"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007306","name":"Arizona Department of Health Services","doi-asserted-by":"publisher","award":["211002"],"award-info":[{"award-number":["211002"]}],"id":[{"id":"10.13039\/100007306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["4001"],"award-info":[{"award-number":["4001"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["0011"],"award-info":[{"award-number":["0011"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["05-901"],"award-info":[{"award-number":["05-901"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["1001"],"award-info":[{"award-number":["1001"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.neuint.2017.08.007","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T12:16:03Z","timestamp":1502712963000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["APP\/A\u03b2 structural diversity and Alzheimer's disease pathogenesis"],"prefix":"10.1016","volume":"110","author":[{"given":"Alex E.","family":"Roher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler A.","family":"Kokjohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7301-230X","authenticated-orcid":false,"given":"Michael R.","family":"Sierks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chera L.","family":"Maarouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geidy E.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan S.","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Beach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2017.08.007_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0197-4580(01)00302-5","article-title":"Reactive astrocytes and alpha1-antichymotrypsin in Alzheimer's disease","volume":"22","author":"Abraham","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2017.08.007_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0092-8674(88)90462-X","article-title":"Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease","volume":"52","author":"Abraham","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2017.08.007_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/psc.626","article-title":"Methionine regulates copper\/hydrogen peroxide oxidation products of Abeta","volume":"11","author":"Ali","year":"2005","journal-title":"J.\u00a0Pept. Sci."},{"key":"10.1016\/j.neuint.2017.08.007_bib4","doi-asserted-by":"crossref","first-page":"11192","DOI":"10.1021\/ic201739n","article-title":"pH-Dependent Cu(II) coordination to amyloid-beta peptide: impact of sequence alterations, including the H6R and D7N familial mutations","volume":"50","author":"Alies","year":"2011","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib5","doi-asserted-by":"crossref","first-page":"19235","DOI":"10.1074\/jbc.R116.746032","article-title":"A\u00a0Greek tragedy: the growing complexity of alzheimer amyloid precursor protein proteolysis","volume":"291","author":"Andrew","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib6","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.2174\/13816128113199990497","article-title":"In\u00a0vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches","volume":"20","author":"Balducci","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuint.2017.08.007_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/protein\/gzl036","article-title":"Isolating recombinant antibodies against specific protein morphologies using atomic force microscopy and phage display technologies","volume":"19","author":"Barkhordarian","year":"2006","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.neuint.2017.08.007_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of alzheimer disease at national Institute on aging alzheimer disease centers, 2005-2010","volume":"71","author":"Beach","year":"2012","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0169-328X(99)00014-5","article-title":"Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein","volume":"66","author":"Berger-Sweeney","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuint.2017.08.007_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/mcne.2001.1030","article-title":"A\u00a0short cytoplasmic domain of the amyloid precursor protein induces apoptosis in\u00a0vitro and in\u00a0vivo","volume":"18","author":"Bertrand","year":"2001","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib12","doi-asserted-by":"crossref","first-page":"32916","DOI":"10.1074\/jbc.271.51.32916","article-title":"Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma","volume":"271","author":"Biere","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1515\/BC.2008.125","article-title":"Isoaspartate-containing amyloid precursor protein-derived peptides alter efficacy and specificity of potential beta-secretases","volume":"389","author":"Bohme","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib14","doi-asserted-by":"crossref","first-page":"15990","DOI":"10.1074\/jbc.274.23.15990","article-title":"Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues","volume":"274","author":"Bohrmann","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.23964","article-title":"Much of late life cognitive decline is not due to common neurodegenerative pathologies","volume":"74","author":"Boyle","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib16","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.2174\/13816128113199990498","article-title":"The effects of soluble Abeta oligomers on neurodegeneration in Alzheimer's disease","volume":"20","author":"Brouillette","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuint.2017.08.007_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.abb.2014.01.002","article-title":"Simulations of monomeric amyloid beta-peptide (1-40) with varying solution conditions and oxidation state of Met35: implications for aggregation","volume":"545","author":"Brown","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuint.2017.08.007_bib18","doi-asserted-by":"crossref","first-page":"e05116","DOI":"10.7554\/eLife.05116","article-title":"Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains","volume":"4","author":"Bushman","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.neuint.2017.08.007_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0196-9781(02)00066-9","article-title":"Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42","volume":"23","author":"Butterfield","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.neuint.2017.08.007_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2009.10.035","article-title":"In\u00a0vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid beta-peptide of APP","volume":"48","author":"Butterfield","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2017.08.007_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.112.195511","article-title":"Hypertension induces brain beta-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature","volume":"60","author":"Carnevale","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.neuint.2017.08.007_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/protein\/11.9.761","article-title":"Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease","volume":"11","author":"Chaney","year":"1998","journal-title":"Protein Eng."},{"key":"10.1016\/j.neuint.2017.08.007_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrneurol.2013.21","article-title":"Alzheimer disease: abeta-independent processes-rethinking preclinical AD","volume":"9","author":"Chetelat","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1523\/JNEUROSCI.4276-04.2005","article-title":"Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42","volume":"25","author":"Crouch","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib229","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/ac303428h","article-title":"Integrated proteomic analysis of major isoaspartyl containing protein in the urine of wild and protein L-isoaspartate O-methyltransferase deficient mice","volume":"85","author":"Dai","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/bip.21271","article-title":"N-terminal truncated pyroglutamyl beta amyloid peptide Abetapy3-42 shows a faster aggregation kinetics than the full-length Abeta1-42","volume":"91","author":"D'Arrigo","year":"2009","journal-title":"Biopolymers"},{"key":"10.1016\/j.neuint.2017.08.007_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11357-012-9403-0","article-title":"Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Abeta pathology at the lysosome","volume":"35","author":"De Kimpe","year":"2013","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.neuint.2017.08.007_bib27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2017.08.007_bib28","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","article-title":"A\u00a0plaque-specific antibody clears existing beta-amyloid plaques in Alzheimer's disease mice","volume":"76","author":"DeMattos","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2017.08.007_bib29","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1523\/JNEUROSCI.1189-06.2006","article-title":"Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons","volume":"26","author":"Deshpande","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib30","doi-asserted-by":"crossref","first-page":"10264","DOI":"10.1523\/JNEUROSCI.1608-14.2014","article-title":"Multiple factors contribute to the peripheral induction of cerebral beta-amyloidosis","volume":"34","author":"Eisele","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib31","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/bi036281f","article-title":"Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments","volume":"43","author":"Emadi","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2017.08.007_bib32","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jmb.2007.02.089","article-title":"Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity","volume":"368","author":"Emadi","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neuint.2017.08.007_bib33","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1074\/jbc.M806559200","article-title":"Detecting morphologically distinct oligomeric forms of alpha-synuclein","volume":"284","author":"Emadi","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib34","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1432-1033.1994.tb18811.x","article-title":"Synthetic post-translationally modified human A beta peptide exhibits a markedly increased tendency to form beta-pleated sheets in\u00a0vitro","volume":"221","author":"Fabian","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jmb.2012.01.006","article-title":"Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity","volume":"421","author":"Fandrich","year":"2012","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neuint.2017.08.007_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","article-title":"Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease","volume":"14","author":"Ferrer","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/BJ20130652","article-title":"Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid beta and the Asn23 Iowa mutation","volume":"456","author":"Fossati","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2017.08.007_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000335913","article-title":"Passive immunization against pyroglutamate-3 amyloid-beta reduces plaque burden in Alzheimer-like transgenic mice: a pilot study","volume":"10","author":"Frost","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuint.2017.08.007_bib39","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0960-894X(99)00121-3","article-title":"Synthesis, aggregation, and neurotoxicity of the Alzheimer's Abeta1-42 amyloid peptide and its isoaspartyl isomers","volume":"9","author":"Fukuda","year":"1999","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.neuint.2017.08.007_bib40","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1471-4159.2004.02828.x","article-title":"Interaction of human and mouse Abeta peptides","volume":"91","author":"Fung","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib41","doi-asserted-by":"crossref","first-page":"21037","DOI":"10.1074\/jbc.272.34.21037","article-title":"Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations","volume":"272","author":"Garzon-Rodriguez","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0021-9258(19)75855-4","article-title":"Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation","volume":"262","author":"Geiger","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib43","doi-asserted-by":"crossref","first-page":"45897","DOI":"10.1074\/jbc.M407668200","article-title":"Systemic catabolism of Alzheimer's Abeta40 and Abeta42","volume":"279","author":"Ghiso","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0896-6273(92)90117-V","article-title":"Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms","volume":"8","author":"Goedert","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2017.08.007_bib45","doi-asserted-by":"crossref","first-page":"10987","DOI":"10.1016\/S0021-9258(19)78080-6","article-title":"Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease","volume":"269","author":"Gowing","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib46","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.biocel.2010.08.015","article-title":"Pyroglutamate-Abeta: role in the natural history of Alzheimer's disease","volume":"42","author":"Gunn","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuint.2017.08.007_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.09579","article-title":"Determining composition of micron-scale protein deposits in neurodegenerative disease by spatially targeted optical microproteomics","volume":"4","author":"Hadley","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.neuint.2017.08.007_bib48","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1006\/bbrc.1995.1912","article-title":"Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease","volume":"211","author":"Harigaya","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2017.08.007_bib49","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/bbrc.2000.3490","article-title":"Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain","volume":"276","author":"Harigaya","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2017.08.007_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1074-5521(97)90255-6","article-title":"Observation of metastable Abeta amyloid protofibrils by atomic force microscopy","volume":"4","author":"Harper","year":"1997","journal-title":"Chem. Biol."},{"key":"10.1016\/j.neuint.2017.08.007_bib51","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm0997-1016","article-title":"Distinct sites of intracellular production for Alzheimer's disease A beta40\/42 amyloid peptides","volume":"3","author":"Hartmann","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2017.08.007_bib52","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1021\/bi990563r","article-title":"The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in\u00a0vitro than full-length A beta","volume":"38","author":"He","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2017.08.007_bib53","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nn.4017","article-title":"The case for rejecting the amyloid cascade hypothesis","volume":"18","author":"Herrup","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib54","first-page":"585","article-title":"P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain","volume":"149","author":"Higgins","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1432-1033.1991.tb16256.x","article-title":"Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4","volume":"201","author":"Hilbich","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2017.08.007_bib57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuron.2014.02.027","article-title":"Soluble abeta oligomers are rapidly sequestered from brain ISF in\u00a0vivo and bind GM1 ganglioside on cellular membranes","volume":"82","author":"Hong","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2017.08.007_bib58","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1074\/jbc.M608220200","article-title":"The Tottori (D7N) and English (H6R) familial Alzheimer disease mutations accelerate Abeta fibril formation without increasing protofibril formation","volume":"282","author":"Hori","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib59","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00005072-199811000-00012","article-title":"Quantification of modified amyloid beta peptides in Alzheimer disease and Down syndrome brains","volume":"57","author":"Hosoda","year":"1998","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib60","doi-asserted-by":"crossref","first-page":"40173","DOI":"10.1074\/jbc.C200338200","article-title":"Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease","volume":"277","author":"Hou","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/JAD-122389","article-title":"Modification of amyloid-beta1-42 fibril structure by methionine-35 oxidation","volume":"37","author":"Hou","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuint.2017.08.007_bib62","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.neurobiolaging.2013.09.040","article-title":"Markers of cholesterol transport are associated with amyloid deposition in the brain","volume":"35","author":"Hughes","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2017.08.007_bib63","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1523\/JNEUROSCI.3916-08.2008","article-title":"Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: abeta dimers and trimers correlate with neurotoxicity","volume":"28","author":"Hung","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib64","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/ac403315h","article-title":"Simultaneous determination of post-translational racemization and isomerization of N-terminal amyloid-beta in Alzheimer's brain tissues by covalent chiral derivatized ultraperformance liquid chromatography tandem mass spectrometry","volume":"86","author":"Inoue","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib65","first-page":"1823","article-title":"Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques","volume":"149","author":"Iwatsubo","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib66","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology - concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib67","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2017.08.007_bib68","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1073\/pnas.0914251107","article-title":"Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome","volume":"107","author":"Jang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2017.08.007_bib69","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1021\/ct300916f","article-title":"Mechanisms for the insertion of toxic, fibril-like beta-amyloid oligomers into the membrane","volume":"9","author":"Jang","year":"2013","journal-title":"J.\u00a0Chem. Theory Comput."},{"key":"10.1016\/j.neuint.2017.08.007_bib70","doi-asserted-by":"crossref","first-page":"38825","DOI":"10.1074\/jbc.R111.288308","article-title":"Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease","volume":"286","author":"Jawhar","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib71","doi-asserted-by":"crossref","first-page":"196.e29","DOI":"10.1016\/j.neurobiolaging.2010.05.027","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2017.08.007_bib72","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration","volume":"108","author":"Jin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2017.08.007_bib73","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/WNR.0b013e3280b07c21","article-title":"Attenuated amyloid-beta aggregation and neurotoxicity owing to methionine oxidation","volume":"18","author":"Johansson","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuint.2017.08.007_bib74","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.21223","article-title":"Beta-amyloid burden is not associated with rates of brain atrophy","volume":"63","author":"Josephs","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2017.08.007_bib76","first-page":"529","article-title":"Protein L-isoaspartyl O-methyltransferase inhibits amyloid beta fibrillogenesis in\u00a0vitro","volume":"66","author":"Jung","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.neuint.2017.08.007_bib77","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0306-4522(01)00155-5","article-title":"Drastic neuronal loss in\u00a0vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments","volume":"104","author":"Kaneko","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2017.08.007_bib78","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/bi902030m","article-title":"Engineered proteolytic nanobodies reduce Abeta burden and ameliorate Abeta-induced cytotoxicity","volume":"49","author":"Kasturirangan","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2017.08.007_bib79","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.neurobiolaging.2010.09.020","article-title":"Nanobody specific for oligomeric beta-amyloid stabilizes nontoxic form","volume":"33","author":"Kasturirangan","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2017.08.007_bib80","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/btpr.1698","article-title":"Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples","volume":"29","author":"Kasturirangan","year":"2013","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.neuint.2017.08.007_bib81","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuint.2017.08.007_bib82","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1021\/bi200147a","article-title":"Single-molecule atomic force microscopy force spectroscopy study of Abeta-40 interactions","volume":"50","author":"Kim","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2017.08.007_bib83","doi-asserted-by":"crossref","first-page":"24041","DOI":"10.1074\/jbc.M116.744722","article-title":"Alternative selection of beta-site APP-cleaving enzyme 1 (BACE1) cleavage sites in amyloid beta-protein precursor (APP) harboring protective and pathogenic mutations within the abeta sequence","volume":"291","author":"Kimura","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib84","doi-asserted-by":"crossref","first-page":"13489","DOI":"10.1038\/srep13489","article-title":"Plaque-associated lipids in Alzheimer's diseased brain tissue visualized by nonlinear microscopy","volume":"5","author":"Kiskis","year":"2015","journal-title":"Sci. Rep."},{"issue":"Suppl 1","key":"10.1016\/j.neuint.2017.08.007_bib85","first-page":"S49","article-title":"Synaptotoxic amyloid-beta oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?","volume":"33","author":"Klein","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuint.2017.08.007_bib86","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neurobiolaging.2004.02.010","article-title":"Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease","volume":"25","author":"Klein","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2017.08.007_bib87","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","article-title":"Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques","volume":"106","author":"Koffie","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2017.08.007_bib88","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.bbadis.2011.07.004","article-title":"Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets","volume":"1812","author":"Kokjohn","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2017.08.007_bib89","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.brainres.2004.10.041","article-title":"Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain","volume":"1031","author":"Kokubo","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2017.08.007_bib90","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/jnr.10391","article-title":"In\u00a0vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35\/40) and fragment presence in the brains of Alzheimer's patients","volume":"70","author":"Kubo","year":"2002","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuint.2017.08.007_bib91","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/jnen\/62.3.248","article-title":"Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease","volume":"62","author":"Kubo","year":"2003","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib92","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/emboj.2011.138","article-title":"Extracellular phosphorylation of the amyloid beta-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease","volume":"30","author":"Kumar","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2017.08.007_bib93","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-013-1107-8","article-title":"Early intraneuronal accumulation and increased aggregation of phosphorylated Abeta in a mouse model of Alzheimer's disease","volume":"125","author":"Kumar","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib94","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/alzrt258","article-title":"Truncated and modified amyloid-beta species","volume":"6","author":"Kummer","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuint.2017.08.007_bib95","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.neuron.2011.07.001","article-title":"Nitration of tyrosine 10 critically enhances amyloid beta aggregation and plaque formation","volume":"71","author":"Kummer","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2017.08.007_bib96","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","article-title":"Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains","volume":"271","author":"Kuo","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib97","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/bbrc.1997.7083","article-title":"Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits","volume":"237","author":"Kuo","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2017.08.007_bib98","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0925-4439(98)00014-3","article-title":"Irreversible dimerization\/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease","volume":"1406","author":"Kuo","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2017.08.007_bib99","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1006\/bbrc.2000.2222","article-title":"Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma","volume":"268","author":"Kuo","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2017.08.007_bib100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0002-9440(10)64947-4","article-title":"Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism","volume":"156","author":"Kuo","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib101","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer's-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib102","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-beta in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib103","doi-asserted-by":"crossref","first-page":"33623","DOI":"10.1074\/jbc.271.52.33623","article-title":"The \u201cnonamyloidogenic\u201d p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid","volume":"271","author":"Lalowski","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib104","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl 1","key":"10.1016\/j.neuint.2017.08.007_bib105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2011.07478.x","article-title":"Soluble Abeta oligomer production and toxicity","volume":"120","author":"Larson","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib106","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnen\/61.2.125","article-title":"Evidence for D-aspartyl-beta-amyloid secretase activity in human brain","volume":"61","author":"Lee","year":"2002","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib107","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/156720506775697124","article-title":"Amyloid beta: the alternate hypothesis","volume":"3","author":"Lee","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuint.2017.08.007_bib108","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1074\/jbc.M511018200","article-title":"Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice","volume":"281","author":"Lee","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib109","doi-asserted-by":"crossref","first-page":"37061","DOI":"10.1074\/jbc.M403672200","article-title":"Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection","volume":"279","author":"Liao","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40478-015-0250-y","article-title":"Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models","volume":"3","author":"Liao","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuint.2017.08.007_bib111","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1021\/bi049933o","article-title":"Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity","volume":"43","author":"Liu","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2017.08.007_bib112","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.aab1785","article-title":"Somatic mutation in single human neurons tracks developmental and transcriptional history","volume":"350","author":"Lodato","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.neuint.2017.08.007_bib113","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1016\/S0021-9258(18)55010-9","article-title":"Structural elements affecting the recognition of L-isoaspartyl residues by the L-isoaspartyl\/D-aspartyl protein methyltransferase. Implications for the repair hypothesis","volume":"266","author":"Lowenson","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib114","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/74656","article-title":"A\u00a0second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor","volume":"6","author":"Lu","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2017.08.007_bib115","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib116","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1038\/srep02880","article-title":"Mechanism of amyloid beta-protein dimerization determined using single-molecule AFM force spectroscopy","volume":"3","author":"Lv","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2017.08.007_bib117","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-5-39","article-title":"The biochemical aftermath of anti-amyloid immunotherapy","volume":"5","author":"Maarouf","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2017.08.007_bib118","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1537-1891(02)00198-2","article-title":"Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions","volume":"38","author":"Mackic","year":"2002","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.neuint.2017.08.007_bib119","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1096\/fj.05-3839fje","article-title":"SET protein (TAF1beta, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain","volume":"19","author":"Madeira","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.neuint.2017.08.007_bib120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3233\/JAD-2011-111208","article-title":"Detection of peri-synaptic amyloid-beta pyroglutamate aggregates in early stages of Alzheimer's disease and in AbetaPP transgenic mice using a novel monoclonal antibody","volume":"28","author":"Mandler","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuint.2017.08.007_bib121","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000148590.39911.DF","article-title":"Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease","volume":"64","author":"Masliah","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2017.08.007_bib122","doi-asserted-by":"crossref","first-page":"a006262","DOI":"10.1101\/cshperspect.a006262","article-title":"Biochemistry of amyloid beta-protein and amyloid deposits in Alzheimer disease","volume":"2","author":"Masters","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuint.2017.08.007_bib123","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1038\/ncomms10918","article-title":"Increased amyloidogenic APP processing in APOE varepsilon4-negative individuals with cerebral beta-amyloidosis","volume":"7","author":"Mattsson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2017.08.007_bib124","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2012.02.041","article-title":"The levels of water-soluble and triton-soluble Abeta are increased in Alzheimer's disease brain","volume":"1450","author":"McDonald","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2017.08.007_bib125","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib126","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1097\/00001756-200112040-00047","article-title":"Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase","volume":"12","author":"Milton","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuint.2017.08.007_bib127","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/0-387-23226-5_20","article-title":"Phosphorylated amyloid-beta: the toxic intermediate in alzheimer's disease neurodegeneration","volume":"38","author":"Milton","year":"2005","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib128","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","article-title":"Abeta-degrading enzymes in Alzheimer's disease","volume":"18","author":"Miners","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib129","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1021\/bi0508237","article-title":"Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques","volume":"44","author":"Miravalle","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2017.08.007_bib130","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1016\/S0021-9258(18)41896-0","article-title":"Mass spectrometry of purified amyloid beta protein in Alzheimer's disease","volume":"267","author":"Mori","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib131","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/jnen\/60.8.778","article-title":"Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice","volume":"60","author":"Mori","year":"2001","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib132","doi-asserted-by":"crossref","first-page":"10687","DOI":"10.1021\/bi201426b","article-title":"Induction of methionine-sulfoxide reductases protects neurons from amyloid beta-protein insults in\u00a0vitro and in\u00a0vivo","volume":"50","author":"Moskovitz","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2017.08.007_bib133","doi-asserted-by":"crossref","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","article-title":"Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction","volume":"2","author":"Mucke","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuint.2017.08.007_bib134","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0197-4580(94)00064-6","article-title":"Apolipoprotein E-immunoreactivity in aged rhesus monkey cortex: colocalization with amyloid plaques","volume":"15","author":"Mufson","year":"1994","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2017.08.007_bib135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bcp.2012.11.014","article-title":"Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?","volume":"85","author":"Mullane","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2017.08.007_bib136","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1016\/j.febslet.2006.09.063","article-title":"alphaB-crystallin competes with Alzheimer's disease beta-amyloid peptide for peptide-peptide interactions and induces oxidation of Abeta-Met35","volume":"580","author":"Narayanan","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2017.08.007_bib137","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1471-4159.1996.67010294.x","article-title":"High-resolution separation of amyloid beta-peptides: structural variants present in Alzheimer's disease amyloid","volume":"67","author":"Naslund","year":"1996","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib138","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1750-3639.2008.00244.x","article-title":"Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons","volume":"20","author":"Nelson","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib141","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2017.08.007_bib142","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/01.jnen.0000240466.10758.ce","article-title":"Abeta species removal after abeta42 immunization","volume":"65","author":"Nicoll","year":"2006","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib143","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nature07767","article-title":"APP binds DR6 to trigger axon pruning and neuron death via distinct caspases","volume":"457","author":"Nikolaev","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2017.08.007_bib144","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature11060","article-title":"Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta","volume":"485","author":"Nussbaum","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2017.08.007_bib145","doi-asserted-by":"crossref","first-page":"23186","DOI":"10.1074\/jbc.M109.086496","article-title":"Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity","volume":"285","author":"Ono","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib146","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/jmbi.1999.2768","article-title":"Induction of beta-sheet structure in amyloidogenic peptides by neutralization of aspartate: a model for amyloid nucleation","volume":"289","author":"Orpiszewski","year":"1999","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neuint.2017.08.007_bib147","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1523\/JNEUROSCI.16-21-06732.1996","article-title":"Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein","volume":"16","author":"Oster-Granite","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib148","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib149","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2009.08.042","article-title":"Mechanism of cytotoxicity mediated by the C31 fragment of the amyloid precursor protein","volume":"388","author":"Park","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2017.08.007_bib150","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2353\/ajpath.2006.060269","article-title":"Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis","volume":"169","author":"Patton","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib151","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/1570159X11311050004","article-title":"Pyroglutamate-modified amyloid beta peptides: emerging targets for alzheimer s disease immunotherapy","volume":"11","author":"Perez-Garmendia","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuint.2017.08.007_bib152","doi-asserted-by":"crossref","first-page":"23895","DOI":"10.1074\/jbc.270.41.23895","article-title":"Amino-terminal deletions enhance aggregation of beta-amyloid peptides in\u00a0vitro","volume":"270","author":"Pike","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib153","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00401-010-0690-1","article-title":"Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease","volume":"120","author":"Portelius","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib154","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/01.wnl.0000191298.68045.50","article-title":"Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease","volume":"66","author":"Prohovnik","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2017.08.007_bib155","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1126\/science.1222951","article-title":"Cell biology. A unifying role for prions in neurodegenerative diseases","volume":"336","author":"Prusiner","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuint.2017.08.007_bib156","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-genet-110711-155524","article-title":"Biology and genetics of prions causing neurodegeneration","volume":"47","author":"Prusiner","year":"2013","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.neuint.2017.08.007_bib157","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.1575-04.2005","article-title":"Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase","volume":"25","author":"Qi-Takahara","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib158","first-page":"9148","volume":"vol. 118","author":"Radkiewicz","year":"1996"},{"key":"10.1016\/j.neuint.2017.08.007_bib159","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2009.03.042","article-title":"Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease","volume":"218","author":"Reddy","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib160","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/S0021-9258(18)53661-9","article-title":"Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease","volume":"268","author":"Roher","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib161","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.90.22.10836","article-title":"beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease","volume":"90","author":"Roher","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2017.08.007_bib162","doi-asserted-by":"crossref","first-page":"20631","DOI":"10.1074\/jbc.271.34.20631","article-title":"Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease","volume":"271","author":"Roher","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib163","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuint.2017.08.007_bib164","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1021\/acschemneuro.5b00180","article-title":"Role of species-specific primary structure differences in Abeta42 assembly and neurotoxicity","volume":"6","author":"Roychaudhuri","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0014-5793(97)00564-4","article-title":"Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains","volume":"409","author":"Russo","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2017.08.007_bib166","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1046\/j.1471-4159.2002.01107.x","article-title":"Pyroglutamate-modified amyloid beta-peptides\u2013AbetaN3(pE)\u2013strongly affect cultured neuron and astrocyte survival","volume":"82","author":"Russo","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib167","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","article-title":"Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques","volume":"14","author":"Saido","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2017.08.007_bib168","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnagi.2014.00290","article-title":"New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy","volume":"6","author":"Saito","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib169","doi-asserted-by":"crossref","first-page":"12393","DOI":"10.1021\/bi0612667","article-title":"On the seeding and oligomerization of pGlu-amyloid peptides (in\u00a0vitro)","volume":"45","author":"Schilling","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2017.08.007_bib170","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1471-4159.2012.07707.x","article-title":"N-Terminal pyroglutamate formation of Abeta38 and Abeta40 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation","volume":"121","author":"Schlenzig","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib171","doi-asserted-by":"crossref","first-page":"11858","DOI":"10.1073\/pnas.1503455112","article-title":"Peptide dimer structure in an Abeta(1-42) fibril visualized with cryo-EM","volume":"112","author":"Schmidt","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2017.08.007_bib172","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2017.08.007_bib173","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuint.2017.08.007_bib174","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2007.10.012","article-title":"Presenilin: running with scissors in the membrane","volume":"131","author":"Selkoe","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2017.08.007_bib175","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","article-title":"The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy","volume":"6","author":"Sengupta","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neuint.2017.08.007_bib176","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1046\/j.1471-4159.2003.01818.x","article-title":"Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach","volume":"85","author":"Sergeant","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib177","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/NEN.0000000000000235","article-title":"Feasibility study: comparison of frontal cortex needle core versus open biopsy for detection of characteristic proteinopathies of neurodegenerative diseases","volume":"74","author":"Serrano","year":"2015","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib178","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2017.08.007_bib179","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/abbi.2000.1955","article-title":"Isoaspartate formation and neurodegeneration in Alzheimer's disease","volume":"381","author":"Shimizu","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuint.2017.08.007_bib180","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1248\/bpb.28.1590","article-title":"Biological significance of isoaspartate and its repair system","volume":"28","author":"Shimizu","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuint.2017.08.007_bib181","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00401-002-0639-0","article-title":"Abeta species, including IsoAsp23 Abeta, in Iowa-type familial cerebral amyloid angiopathy","volume":"105","author":"Shin","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib182","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/j.1460-2075.1988.tb02952.x","article-title":"Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact","volume":"7","author":"Shivers","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2017.08.007_bib183","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1039\/c1ib00018g","article-title":"CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease","volume":"3","author":"Sierks","year":"2011","journal-title":"Integr. Biol. (Camb )"},{"key":"10.1016\/j.neuint.2017.08.007_bib184","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1523\/JNEUROSCI.16-03-00899.1996","article-title":"Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons","volume":"16","author":"Simons","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib185","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1021\/jacs.6b02816","article-title":"Atomic details of the interactions of glycosaminoglycans with amyloid-beta fibrils","volume":"138","author":"Stewart","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.neuint.2017.08.007_bib186","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/psc.2456","article-title":"Structural analysis of the pyroglutamate-modified isoform of the Alzheimer's disease-related amyloid-beta using NMR spectroscopy","volume":"18","author":"Sun","year":"2012","journal-title":"J.\u00a0Pept. Sci."},{"key":"10.1016\/j.neuint.2017.08.007_bib187","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1432-1033.1994.t01-1-00917.x","article-title":"Aspartate-bond isomerization affects the major conformations of synthetic peptides","volume":"226","author":"Szendrei","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib188","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1399-3011.1996.tb01358.x","article-title":"The effects of aspartic acid-bond isomerization on in\u00a0vitro properties of the amyloid beta-peptide as modeled with N-terminal decapeptide fragments","volume":"47","author":"Szendrei","year":"1996","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.neuint.2017.08.007_bib189","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1006\/bbrc.1994.1634","article-title":"Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid","volume":"200","author":"Tabaton","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2017.08.007_bib190","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","article-title":"gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment","volume":"29","author":"Takami","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib191","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1271\/bbb.120797","article-title":"Racemization of the aspartic acid residue of amyloid-beta peptide by a radical reaction","volume":"77","author":"Tambo","year":"2013","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib192","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00005072-199801000-00009","article-title":"N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits","volume":"57","author":"Tekirian","year":"1998","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib193","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm0196-93","article-title":"Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome","volume":"2","author":"Teller","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2017.08.007_bib194","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2353\/ajpath.2010.090636","article-title":"Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits","volume":"176","author":"Tomidokoro","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-9-48","article-title":"Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease","volume":"9","author":"Tu","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2017.08.007_bib196","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2119\/2007-00094.VanVickle","article-title":"Presenilin-1 280Glu-->Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer's disease","volume":"14","author":"Van Vickle","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuint.2017.08.007_bib197","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0361-9230(99)00093-3","article-title":"Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress","volume":"50","author":"Varadarajan","year":"1999","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuint.2017.08.007_bib198","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JAD-2011-111379","article-title":"Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-beta in a fraction of amyloid-beta deposits in Alzheimer's disease without cross-reactivity with other protein aggregates","volume":"29","author":"Venkataramani","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuint.2017.08.007_bib199","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1021\/cn400110d","article-title":"Effect of the Tottori familial disease mutation (D7N) on the monomers and dimers of Abeta40 and Abeta42","volume":"4","author":"Viet","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2017.08.007_bib201","doi-asserted-by":"crossref","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","article-title":"Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates","volume":"274","author":"Walsh","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib202","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in\u00a0vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2017.08.007_bib203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0006-8993(01)03058-X","article-title":"Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus","volume":"924","author":"Wang","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2017.08.007_bib204","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1021\/acs.biochem.5b00968","article-title":"Correction to cathepsin l mediates the degradation of novel APP C-Terminal fragments","volume":"54","author":"Wang","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2017.08.007_bib205","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1179\/016164105X49436","article-title":"Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease","volume":"27","author":"Watson","year":"2005","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuint.2017.08.007_bib206","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00401-013-1083-z","article-title":"Oligomers, fact or artefact? SDS-PAGE induces dimerization of beta-amyloid in human brain samples","volume":"125","author":"Watt","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib207","doi-asserted-by":"crossref","first-page":"10323","DOI":"10.1073\/pnas.1408900111","article-title":"Serial propagation of distinct strains of Abeta prions from Alzheimer's disease patients","volume":"111","author":"Watts","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2017.08.007_bib208","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature14864","article-title":"eta-Secretase processing of APP inhibits neuronal activity in the hippocampus","volume":"526","author":"Willem","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2017.08.007_bib209","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1111\/j.1742-4658.2011.08228.x","article-title":"Membrane and surface interactions of Alzheimer's Abeta peptide\u2013insights into the mechanism of cytotoxicity","volume":"278","author":"Williams","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.neuint.2017.08.007_bib210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ejn.13056","article-title":"Oligomeric alpha-synuclein and beta-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases","volume":"43","author":"Williams","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib211","doi-asserted-by":"crossref","first-page":"41517","DOI":"10.1074\/jbc.M110.178707","article-title":"Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis","volume":"285","author":"Wirths","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib212","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.bbadis.2010.05.004","article-title":"Murine models of Alzheimer's disease and their use in developing immunotherapies","volume":"1802","author":"Wisniewski","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2017.08.007_bib213","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.embor.7400896","article-title":"When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42\/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease","volume":"8","author":"Wolfe","year":"2007","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neuint.2017.08.007_bib214","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11910-013-0412-x","article-title":"Amyloid imaging in atypical presentations of Alzheimer's disease","volume":"13","author":"Wolk","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuint.2017.08.007_bib215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-2009-0957","article-title":"Gamma-secretase catalyzes sequential cleavages of the AbetaPP transmembrane domain","volume":"16","author":"Xu","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuint.2017.08.007_bib216","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1523\/JNEUROSCI.1042-08.2008","article-title":"Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice","volume":"28","author":"Xu","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.08.007_bib217","first-page":"593","article-title":"Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain","volume":"135","author":"Yamaguchi","year":"1989","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2017.08.007_bib218","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1471-4159.2010.07006.x","article-title":"Pathological significance of ganglioside clusters in Alzheimer's disease","volume":"116","author":"Yanagisawa","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2017.08.007_bib219","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1021\/pr900428m","article-title":"Toward proteome-scale identification and quantification of isoaspartyl residues in biological samples","volume":"8","author":"Yang","year":"2009","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.neuint.2017.08.007_bib220","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12035-010-8121-9","article-title":"Membrane biophysics and mechanics in Alzheimer's disease","volume":"41","author":"Yang","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2017.08.007_bib221","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.neurobiolaging.2007.03.005","article-title":"N-truncated amyloid-beta oligomers induce learning impairment and neuronal apoptosis","volume":"29","author":"Youssef","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2017.08.007_bib222","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1039\/c3cp44448a","article-title":"Molecular interactions of Alzheimer amyloid-beta oligomers with neutral and negatively charged lipid bilayers","volume":"15","author":"Yu","year":"2013","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.neuint.2017.08.007_bib223","doi-asserted-by":"crossref","first-page":"11532","DOI":"10.1021\/bi060601o","article-title":"Single chain Fv antibodies against the 25-35 Abeta fragment inhibit aggregation and toxicity of Abeta42","volume":"45","author":"Zameer","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2017.08.007_bib224","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jmb.2008.09.068","article-title":"Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cells","volume":"384","author":"Zameer","year":"2008","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neuint.2017.08.007_bib225","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1038\/ncomms9762","article-title":"Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease","volume":"6","author":"Zhang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2017.08.007_bib226","doi-asserted-by":"crossref","first-page":"50647","DOI":"10.1074\/jbc.C400473200","article-title":"Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein","volume":"279","author":"Zhao","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2017.08.007_bib227","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/tx500353s","article-title":"Nitration of Y10 in Abeta1-40: is it a compensatory reaction against oxidative\/nitrative stress and Abeta aggregation?","volume":"28","author":"Zhao","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.neuint.2017.08.007_bib228","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ymthe.2004.08.019","article-title":"A\u00a0human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein","volume":"10","author":"Zhou","year":"2004","journal-title":"Mol. Ther."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018617302334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018617302334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:43:49Z","timestamp":1759311829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018617302334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":228,"alternative-id":["S0197018617302334"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2017.08.007","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APP\/A\u03b2 structural diversity and Alzheimer's disease pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2017.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}